Antibiotic Use in Outpatients and Hospitals

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 5698

Special Issue Editor


E-Mail Website
Guest Editor
Department of Traslational Medicine, Infectious Diseases Unit, University ‘S. Anna’ Hospital of Ferrara, 44124 Ferrara, Italy
Interests: antimicrobial therapy; multidrug-resistant bacteria; immunocompromised patients; human parasitic diseases; antibiotic stewardship
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Increasingly growing antimicrobial resistance represents a real global emergency that calls for particular attention on the appropriate use of antibiotics, especially those recently introduced for the treatment of infections with multidrug-resistant organisms (MDROs).

Outpatient antibiotic therapy (OPAT) allows for a reduction in hospitalization days, allowing the patient to have a better quality of life if they can finish the antibiotic treatment cycle at home. OPAT also makes it possible to avoid hospitalization itself for the treatment of infections in patients at low risk of clinical complications. Early discharge and de-hospitalization lower the risk of exposing the patient to hospital infections from MDRO and avoid hypokinetic syndrome due to prolonged hospitalization in elderly patients, reducing the management costs of infectious diseases themselves.

The correct use of antibiotics in hospitalized patients requires the definition of appropriateness criteria for the prescription and adequate dosages and times of antibiotic therapy. For this purpose, for example, it would be important to distinguish bacterial colonization from infection to reserve therapy for patients suffering with the latter. It is also important to implement careful source control.

The correlation between antimicrobial therapy in hospital and OPAT is increasingly topical. This Special Issue seeks contributions that can better define aspects related to OPAT and hospital therapy. Particularly encouraged are those contributions that encompass a novel aspect in the definition of criteria for the appropriateness of antibiotic therapy in two settings.

Dr. Rosario Cultrera
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial resistance
  • outpatient
  • epidemiology
  • in hospital infections
  • antibiotic stewardship
  • source control
  • antibiotic prescribing

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 1939 KiB  
Article
Exploring the Impact of Antibiotics on Fever Recovery Time and Hospital Stays in Children with Viral Infections: Insights from Advanced Data Analysis
by Mohammed Al Qahtani, Saleh Fahad AlFulayyih, Sarah Saleh Al Baridi, Sara Amer Alomar, Ahmed Nawfal Alshammari, Reem Jassim Albuaijan and Mohammed Shahab Uddin
Antibiotics 2024, 13(6), 518; https://doi.org/10.3390/antibiotics13060518 - 1 Jun 2024
Viewed by 748
Abstract
Background: Antibiotic overuse in pediatric patients with upper respiratory tract infections (UR-TIs) raises concerns about antimicrobial resistance. This study examines the impact of antibiotics on hospital stay duration and fever resolution in pediatric patients diagnosed with viral infections via a multiplex polymerase chain [...] Read more.
Background: Antibiotic overuse in pediatric patients with upper respiratory tract infections (UR-TIs) raises concerns about antimicrobial resistance. This study examines the impact of antibiotics on hospital stay duration and fever resolution in pediatric patients diagnosed with viral infections via a multiplex polymerase chain reaction (PCR) respiratory panel. Methods: In the pediatric ward of Imam Abdulrahman Bin Faisal Hospital, a retrospective cohort analysis was conducted on pediatric patients with viral infections confirmed by nasopharyngeal aspirates from October 2016 to December 2021. Cohorts receiving antibiotics versus those not receiving them were balanced using the gradient boosting machine (GBM) technique for propensity score matching. Results: Among 238 patients, human rhinovirus/enterovirus (HRV/EV) was most common (44.5%), followed by respiratory syncytial virus (RSV) (18.1%). Co-infections occurred in 8.4% of cases. Antibiotic administration increased hospital length of stay (LOS) by an average of 2.19 days (p-value: 0.00). Diarrhea reduced LOS by 2.26 days, and higher albumin levels reduced LOS by 0.40 days. Fever and CRP levels had no significant effect on LOS. Time to recovery from fever showed no significant difference between antibiotic-free (Abx0) and antibiotic-received (Abx1) groups (p-value: 0.391), with a hazard ratio of 0.84 (CI: 0.57–1.2). Conclusions: Antibiotics did not expedite recovery but were associated with longer hospital stays in pediatric patients with acute viral respiratory infections. Clinicians should exercise caution in prescribing antibiotics to pediatric patients with confirmed viral infections, especially when non-critical. Full article
(This article belongs to the Special Issue Antibiotic Use in Outpatients and Hospitals)
Show Figures

Figure 1

11 pages, 1028 KiB  
Article
The Application of Knowledge-Based Clinical Decision Support Systems to Detect Antibiotic Allergy
by Nayoung Han, Ock Hee Oh, John Oh, Yoomi Kim, Younghee Lee, Won Chul Cha and Yun Mi Yu
Antibiotics 2024, 13(3), 244; https://doi.org/10.3390/antibiotics13030244 - 7 Mar 2024
Viewed by 1170
Abstract
Prevention of drug allergies is important for patient safety. The objective of this study was to evaluate the outcomes of antibiotic allergy-checking clinical decision support system (CDSS), K-CDSTM. A retrospective chart review study was performed in 29 hospitals and antibiotic allergy [...] Read more.
Prevention of drug allergies is important for patient safety. The objective of this study was to evaluate the outcomes of antibiotic allergy-checking clinical decision support system (CDSS), K-CDSTM. A retrospective chart review study was performed in 29 hospitals and antibiotic allergy alerts data were collected from May to August 2022. A total of 15,535 allergy alert cases from 1586 patients were reviewed. The most frequently prescribed antibiotics were cephalosporins (48.5%), and there were more alerts of potential cross-reactivity between beta-lactam antibiotics than between antibiotics with the same ingredients or of the same class. Regarding allergy symptoms, dermatological disorders were the most common (38.8%), followed by gastrointestinal disorders (28.4%). The 714 cases (4.5%) of immune system disorders included 222 cases of anaphylaxis and 61 cases of severe cutaneous adverse reactions. Alerts for severe symptoms were reported in 6.4% of all cases. This study confirmed that K-CDS can effectively detect antibiotic allergies and prevent the prescription of potentially allergy-causing antibiotics among patients with a history of antibiotic allergies. If K-CDS is expanded to medical institutions nationwide in the future, it can prevent an increase in allergy recurrence related to drug prescriptions through cloud-based allergy detection CDSSs. Full article
(This article belongs to the Special Issue Antibiotic Use in Outpatients and Hospitals)
Show Figures

Figure 1

13 pages, 1479 KiB  
Article
Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram-Negative Bacilli Bacteremia: A Randomized Double-Blind Clinical Study
by Carlos Arturo Álvarez-Moreno, Laura Cristina Nocua-Báez, Guillermo Ortiz, Juan Carlos Torres, Gabriel Montenegro, Williams Cervera, Luis Fernando Zuluaga and Alonso Gómez
Antibiotics 2024, 13(3), 229; https://doi.org/10.3390/antibiotics13030229 - 29 Feb 2024
Cited by 1 | Viewed by 1599
Abstract
Introduction: The objective of this study was to compare the continuous infusion of cefepime with the intermittent infusion in patients with sepsis caused by Gram-negative bacilli (GNB). Methods: Randomized 1:1 multicenter double-blinded placebo-controlled study with allocation concealment; multicenter study in the intensive care [...] Read more.
Introduction: The objective of this study was to compare the continuous infusion of cefepime with the intermittent infusion in patients with sepsis caused by Gram-negative bacilli (GNB). Methods: Randomized 1:1 multicenter double-blinded placebo-controlled study with allocation concealment; multicenter study in the intensive care units of Colombia. Patients with sepsis, severe sepsis or septic shock, and GNB-suspected bacteremia. Cefepime was administered for 7 to 14 days over 30 m intermittently every 8 h over 24 h plus continuous saline solution (0.9%) (G1) or 3 g administered continuously plus saline solution every 8 h (0.9%) (G2). The percentage of clinical response at 3, 7, and 14 days, relapse at 28 days, and mortality at discharge were measured. Results: The recruitment was stopped at the suggestion of the Institutional Review Board (IRB) following an FDA alert about cefepime. Thirty-two patients were randomized; 25 received the intervention, and GNB bacteremia was confirmed in 16 (9 G1 and 7 G2). Favorable clinical response in days 3, 7, and 14 was 88.8%, 88.8%, and 77.8% (G1) and was similar for G2 (85.7%). There were no relapses or deaths in G2, while in G1, one relapse and two deaths were observed. Conclusions: The results of this study support the use of cefepime for the treatment of Gram-negative infections in critically ill patients, but we could not demonstrate differences between continuous or intermittent administration because of the small sample size, given the early suspension of the study. Full article
(This article belongs to the Special Issue Antibiotic Use in Outpatients and Hospitals)
Show Figures

Figure 1

11 pages, 2265 KiB  
Article
Community Antibiotic Consumption in Cyprus for the Period 2015 to 2022
by Eirini Mitsoura, Ioannis Kopsidas, Pambos Charalambous, Georgios Papazisis, Nikolaos Raikos and Zoi Dorothea Pana
Antibiotics 2024, 13(1), 52; https://doi.org/10.3390/antibiotics13010052 - 4 Jan 2024
Viewed by 1738
Abstract
Background: Cyprus currently reports to ESAC-Net the total consumption of antimicrobials, without distinguishing between hospital and community-based antibiotic use. As a result, these data can only provide generalized insights into antimicrobial trends in the country. Aim: This study is a first attempt to [...] Read more.
Background: Cyprus currently reports to ESAC-Net the total consumption of antimicrobials, without distinguishing between hospital and community-based antibiotic use. As a result, these data can only provide generalized insights into antimicrobial trends in the country. Aim: This study is a first attempt to retrospectively analyze community antibiotic consumption in Cyprus for the period of 2015 to 2022. Material and Methods: Data on community antimicrobial consumption between 2015 and 2022 were extracted from Pharmatrack’s database. Orally administered dispensed antibiotics were categorized under the J01 group of the WHO Anatomical Therapeutic Chemical (ATC) classification and by the WHO’s AWaRe classification of antibiotics. Antibiotic consumption was calculated in both packages consumed and per 1000 inhabitants, overall, by year of consumption and districts. Results: During the period of 2015–2022, there was variability in the mean outpatient antibiotic consumption per 1000 inhabitants among the five districts in Cyprus. Community consumption increased by 38% throughout the study period. Additionally, a decrease of 3% in the consumption of WHO ‘Access’ antibiotics was observed, accompanied with a concurrent increase of 3% in the ‘Watch’ group. Specifically, in 2022 the WHO ‘Access’ group consumption in the Cypriot community was 48%, significantly lower than the WHO’s goal of 60% and the EU’s goal of 70% for ‘Access’ antibiotic consumption. Conclusions: Antibiotic consumption in the community of Cyprus between 2015 and 2022 demonstrated substantial variability among districts, with higher consumption in less populated areas. There was an increasing trend in community consumption over the years and a decreasing trend in the percentage of ‘Access’ antibiotics prescribed. Full article
(This article belongs to the Special Issue Antibiotic Use in Outpatients and Hospitals)
Show Figures

Figure 1

Back to TopTop